RenovoRx has been selected for the 10th Annual BayBio Entrepreneur and Investor Roundtables to be held on February 14, 2013 in San Francisco. The BayBio Roundtables facilitate introductions, dialogue and connections between life science entrepreneurs and investors. If you are an attending founder, executive or investor and want to meet us at the event, please contact us. We are looking forward to hearing from you.
RenovoRx at BayBio Entrepreneur and Investor Roundtables
- RenovoRx Announces Sixth U.S. Patent
- RenovoRx Announces Orphan Drug Designation Granted for Treating Bile Duct Cancer
- Parexel Biotech and RenovoRx Reach Key Milestone in Pancreatic Cancer Clinical Trial for Locally-Advanced Pancreatic Cancer
- RenovoRx Announces Issuance of Fifth U.S. Patent
- Contemporary Management of Pancreatic Cancer